Braun Stacey Associates Inc. Raises Stake in Colgate-Palmolive (NYSE:CL)

Braun Stacey Associates Inc. raised its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 8.7% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 250,787 shares of the company's stock after buying an additional 19,967 shares during the period. Braun Stacey Associates Inc.'s holdings in Colgate-Palmolive were worth $22,799,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth about $32,000. Hager Investment Management Services LLC purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth about $36,000. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $42,000. Roxbury Financial LLC purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth about $43,000. Finally, Synergy Asset Management LLC purchased a new stake in shares of Colgate-Palmolive in the 4th quarter worth about $49,000. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Stock Performance

Shares of NYSE CL traded up $1.69 during trading on Friday, reaching $89.56. 4,747,229 shares of the company traded hands, compared to its average volume of 4,884,892. The firm has a 50 day simple moving average of $88.94 and a 200-day simple moving average of $95.91. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The stock has a market capitalization of $72.68 billion, a PE ratio of 25.44, a P/E/G ratio of 4.18 and a beta of 0.44. Colgate-Palmolive has a 52-week low of $84.45 and a 52-week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter in the prior year, the firm posted $0.87 EPS. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive's payout ratio is presently 56.82%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CL shares. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating for the company in a research report on Monday, January 6th. Barclays decreased their price target on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday, January 17th. UBS Group decreased their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a "buy" rating for the company in a research note on Monday, February 3rd. Raymond James reiterated an "outperform" rating and issued a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. Finally, Royal Bank of Canada reiterated a "sector perform" rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive presently has a consensus rating of "Hold" and an average price target of $101.16.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.